| Whole patient cohort | Patients not taking antidiabetic and/or lipid lowering drugs | ||||
---|---|---|---|---|---|---|
 | All patients (n = 129) | Males (n = 46) | Females (n = 83) | All patients (n = 104) | Males (n = 30) | Females (n = 74) |
Age (yr) | 51.95 ± 10.1 | 51.4 ± 9.6 | 52.3 ± 10.5 | 50.9 ± 10.1 | 49.4 ± 10.2 | 51.5 ± 10.1 |
Weight (kg) | 95.8 ± 13.8 | 102.7 ± 12.3 | 91.9 ± 13.1** | 94.4 ± 13.2 | 100.2 ± 11.9 | 92.0 ± 13.1* |
Height (cm) | 161.8 ± 9.4 | 171.6 ± 6.7 | 156.4 ± 5.5* | 160.6 ± .8.5 | 1.7 ± .05 | 160 ± 5.7** |
Systolic Arterial Pressure (mmHg) | 130.0 (125–140) | 130.0 (125–140) | 130.0 (125–140) | 130.0 (125–140) | 132.0 (128.8–140.0) | 130.0 (125–140) |
Diaystolic Arterial Pressure (mmHg) | 85.0 (75.0–90.0) | 85.0 (80.0–91.3) | 85.0 (75.0–90.0) | 85.0 (75.0–90.0) | 85.0 (80.0–91.3) | 85.0 (75.0–90.0) |
WC (cm) | 112.8 ± 10.5 | 116.1 ± 9.3 | 110.9 ± 10.7* | 111.8 ± 9.8 | 114.3 ± 8.3 | 110.7 ± 10.3 |
BMI (kg/m2) | 35.5 (32.4–40.7) | 33.7 (32.0–37.6) | 36.7 (33.5–42.0)* | 35.7 (32.4–40.6) | 33.1 (31.8–36.8) | 36.9 (33.5–41.5)* |
VAI | 1.9 (1.2–2.8) | 2.1 (1.4–3.1) | 1.8 (1.2–2.6) | 1.8 (1.2–2.6) | 2.0 (1.4–3.5) | 1.8 (1.2–2.5) |
TBW% | 44.9 ± 5.6 | 50.6 ± 2.9 | 41.7 ± 3.9** | 44.3 ± 5.4 | 50.8 ± 2.9 | 41.7 ± 3.8** |
ECW% | 43.0 ± 4.4 | 41.4 ± 4.1 | 43.9 ± 4.4** | 43.1 ± 4.5 | 40.8 ± 3.7 | 44.1 ± 4.5** |
FM% | 39.8 ± 7.5 | 32.5 ± 4.3 | 43.8 ± 5.6** | 40.3 ± 7.6 | 31.6 ± 4.6 | 43.8 ± 5.4** |
MM% | 42.3 ± 8.4 | 45.0 ± 8.6 | 40.8 ± 7.9 | 42.2 ± 8.2 | 46.2 ± 8.2 | 40.6 ± 7.6 |
Plasma Glusose (mg/dl) | 98.0 (91.0–107.0) | 101.0 (93.5–112.0) | 96.0 (88.0–107.0) | 96.5 (88.8–106.0) | 99.0 (92.0–107.0) | 95.0 (87.0–105.5) |
Total Cholesterol (mg/dl) | 201.0 ± 40.3 | 196.8 ± 44.1 | 203.3 ± 38.1 | 204.8 ± 38.9 | 210.3 ± 41.7 | 202.6 ± 37.9 |
HDL Cholesterol (mg/dl) | 49.0 ± 11.4 | 41.7 ± 9.4 | 53.0 ± 10.5** | 49.8 ± 11.5 | 41.5 ± 9.4 | 53.1 ± 10.6** |
LDL Cholesterol (mg/dl) | 134.2 ± 38.1 | 118.1 ± 34.8 | 143.6 ± 37.4 | 127.9 ± 36.1 | 133.1 ± 39.7 | 125.8 ± 34.6 |
Triglycerides (mg/dl) | 131.0 (92.0–169.5) | 143.0 (103.3–211.8) | 118.0 (85.0–158.0)* | 123.0 (88.3–168.8) | 148.5 (102.3–227.5) | 116.5 (82.5–154.3)* |
Triglycerides/HDL ratio | 2.7 (1.7–3.8) | 3.5 (2.3–5.3) | 2.3 (1.5–3.1)** | 2.5 (1.6–3.5) | 3.5 (2.3–5.8) | 116.5 (82.5–154.3)** |
SGOT | 23.0 (18.0–29.5) | 26.0 (21.8–36.0) | 21.0 (17.0–25.0)** | 23 (18–19) | 28.0 (22.0–36.0) | 21.0 (17.0–25.0)** |
SGPT | 28.0 (19.0–43.5) | 43.0 (28.0–61.3) | 22.0 (16.0–31.0)** | 27 (18.5–41) | 43.0 (28.0–61.0) | 22.0 (16.8–31.0)** |